West Pharmaceutical Services Inc. (WST)
WST · Health Care · 
United States
West Pharmaceutical Services Inc. (WST) is a US company in the Health Care sector. The stock has its largest weight in XUHL (MSCI USA Health Care), at 0.44%. Anyone who holds an ETF containing West Pharmaceutical Services also has an indirect stake in the company.
Data and Charts: West Pharmaceutical Services
Key Data for West Pharmaceutical Services
West Pharmaceutical Services Stock Price Chart
The West Pharmaceutical Services chart shows daily closing prices and is set to the current year by default. The stock is up 50.0% year to date and up 48.1% over twelve months. The last recorded close on October 30, 2026, was $412.62, at 98% of the 52-week range.
Price series from our database since Aug 12, 2024, 558 daily values.
West Pharmaceutical Services Stock Performance
| Year to date | +50.0% | 1 year | +48.1% |
|---|---|---|---|
| 1 month | +11.3% | 3 months | +21.0% |
| Calendar year 2025 | -16.0% |
Measured in euros, West Pharmaceutical Services is up 57.7% year to date and up 53.1% over twelve months. The difference from the dollar figures above comes from the exchange rate alone. Each daily price is converted at the ECB euro reference rate for that day.
Alysly Data Analysis: West Pharmaceutical Services
What ETF Is West Pharmaceutical Services In?
West Pharmaceutical Services has above-average ETF coverage and is held by 23 of the 104 ETFs we track, which together follow 12 indices. That puts the stock in more ETFs than 87.8% of the 4,341 stocks we track.
| ETF | Index | Weight | per €1,000 in the ETF |
|---|---|---|---|
| XUHL / XUHC | MSCI USA Health Care | 0.44% | €4.38 |
| SPFS | MSCI World Health Care | 0.33% | €3.31 |
| XDWH | MSCI World Health Care | 0.32% | €3.24 |
| XDEW | S&P 500 Equal Weight | 0.24% | €2.41 |
| 2B7K | MSCI World SRI | 0.13% | €1.30 |
| SPYD | S&P High Yield Dividend Aristocrats | 0.12% | €1.19 |
| SPYI / SPSA | MSCI ACWI IMI | 0.07% | €0.67 |
| XDEM | MSCI World Momentum | 0.05% | €0.54 |
| XD9U / XD9D | MSCI USA | 0.04% | €0.44 |
| SPYL / SPY5 | S&P 500 | 0.04% | €0.43 |
| SXR8 | S&P 500 | 0.04% | €0.40 |
| XDWD / XDWL | MSCI World | 0.03% | €0.33 |
| EUNL | MSCI World | 0.03% | €0.30 |
| IUSQ | MSCI ACWI | 0.03% | €0.30 |
| SWWD | MSCI World | 0.03% | €0.30 |
| SPPW | MSCI World | 0.03% | €0.30 |
| WIMI | MSCI World IMI | 0.03% | €0.30 |
| SPYY | MSCI ACWI | 0.03% | €0.27 |
The last column shows how much of €1,000 in one of these funds goes to West Pharmaceutical Services, based on each fund's latest holdings list.
US-listed ETFs holding West Pharmaceutical Services (weight per latest SEC filing): VUG 0.09%, IVV 0.04%, SPY 0.04%, VOO 0.04%, VTI 0.04%. These funds are registered in the US; retail investors in the EU usually cannot buy them.
West Pharmaceutical Services Weight in iShares Core MSCI World (EUNL) Since 2019
In iShares Core MSCI World (EUNL), West Pharmaceutical Services had a weight of 0.02% on Dec 31, 2019 and 0.03% on Oct 30, 2026. The fund tracks the MSCI World. Its share peaked at 0.05% on Sep 30, 2021. The weight rises and falls with the stock's price performance relative to the other index members. It can also change when the index provider adjusts the index composition.
What's Inside Your ETF Portfolio and the ETF overlap check show how much West Pharmaceutical Services overlaps with the rest of a portfolio.
Which Tracked Investors Hold West Pharmaceutical Services?
West Pharmaceutical Services is not among the largest purchases in the quarter ending Jun 30, 2026. The list is led by GOOGL, DAL and NEBIUS GROUP N.V. The only manager we track that holds West Pharmaceutical Services reduced its position.
| Investor | Shares | Value | Quarter |
|---|---|---|---|
| Bridgewater Associates | 10,429 | $4M | reduced by 12,732 |
As of Jun 30, 2026. Based on quarterly filings with the US securities regulator, submitted up to 45 days after the reference date. The change counts shares, not price gains.
Stocks With ETF Exposure Similar to West Pharmaceutical Services
| Stock | Shared ETFs | r | 1 year | Annualized volatility | Net margin | Revenue growth |
|---|---|---|---|---|---|---|
| West Pharmaceutical Services | – | – | +48.1% | 45.4% | 16.1% | +6.3% |
| STERIS | 22 | – | -3.8% | 23.8% | 13.2% | +8.7% |
 Humana | 22 | – | +45.1% | 46.1% | 0.9% | +10.1% |
 Quest Diagnostics Incorporated | 22 | – | +43.3% | 22.9% | 9.0% | +11.8% |
| Agilent Technologies | 21 | – | +22.0% | 31.4% | 18.8% | +6.7% |
 IQVIA Holdings Inc | 21 | – | +23.5% | 38.6% | 8.3% | +5.9% |
 Mettler-Toledo International | 21 | +0.48 | +21.6% | 32.4% | 21.6% | +4.0% |
 Stryker Corporation | 21 | – | -20.9% | 25.8% | 12.9% | +11.2% |
 Veeva Systems | 21 | – | +9.8% | 38.7% | 28.4% | +16.3% |
These stocks reach a portfolio through largely the same funds as West Pharmaceutical Services. “Shared ETFs” counts the funds that hold both.
Return and volatility are calculated from our daily closing prices in US dollars. Margin and growth come from each company's latest SEC annual filing. Because fiscal years do not end on the same date for every company, the underlying periods are not fully identical.
Fundamental Analysis: West Pharmaceutical Services
West Pharmaceutical Services Key Financials
Figures come from the SEC annual filing for the latest reported fiscal year (period end Dec 31, 2025).
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| FY ended Dec 2023 | 2.9 | 0.6 | 20.1% |
| FY ended Dec 2024 | 2.9 | 0.5 | 17.0% |
| FY ended Dec 2025 | 3.1 | 0.5 | 16.1% |
Technical Analysis: West Pharmaceutical Services
West Pharmaceutical Services Risk Metrics
The close on Oct 30, 2026, was 1.0% below the highest close since Aug 12, 2024. That high was reached on Oct 29, 2026. When the S&P 500 rose or fell 1%, West Pharmaceutical Services moved 0.61% on average in the same direction (past 252 trading days). The correlation of 0.25, however, shows only a moderate link to the broad market. Accordingly, moves in the S&P 500 explain only a small part of the daily price moves of West Pharmaceutical Services.
What West Pharmaceutical Services Correlates With
| Instrument | r | −1 … +1 |
|---|---|---|
| HYPE | +0.49 | |
| Mettler-Toledo International Inc. | +0.48 | |
| Waters Corporation | +0.45 | |
| Revvity Inc. | +0.41 | |
| American Express Company | +0.40 | |
| Thermo Fisher Scientific Inc. | +0.39 | |
| YB | -0.54 | |
| XNO | -0.53 | |
| DEXE | -0.51 |
The strongest co-movers are listed at the top, the strongest inverse movers at the bottom. Low or negative correlations can help spread risk more broadly across a portfolio.
